Dozens of instruments. One piece of music — if they can hear each other.
Sections that can't hear each other. Data out of tune.
Effort everywhere — and no score.
Diligence, data and models — end to end — until every part plays in time.
Most billable hours go to groundwork: searching, reading, extracting, reconciling. We take raw information — PDFs, court files, registries, lab reports, spreadsheets — structure it and build the inference layer on top: the analysis that answers the question, and the agents that keep answering it. Point it at a counterparty and it's due diligence; point it at your own records and it's data analysis.
To build a future where any company, whatever its size, decides with all of its information — every document structured, every figure traceable to its source — because reading everything finally costs less than guessing.
Most firms use AI the way everyone does: generic prompts, generic outputs. We don't. We treat AI as a strategic discipline — trained on your context, embedded in your operations, and engineered to deliver results that a general-purpose tool cannot. From insight to infrastructure, we help organisations turn AI from a buzzword into a competitive advantage.
We build AI systems tailored to each engagement — trained on your data, your sector, and your strategic questions. The result is analysis no off-the-shelf model can replicate: sharper, more defensible, and genuinely proprietary to your decision-making.
We help organisations move beyond experimentation. Through targeted assessments, use-case design, and implementation roadmaps, we identify where generative AI creates measurable value — and where it doesn't — so investment follows opportunity, not hype.
We design, develop, and deploy bespoke AI agents that operate inside your business — automating workflows, augmenting teams, and executing tasks at scale. From architecture to integration to ongoing optimisation, we deliver the full stack, not just the strategy.
Every system we ship comes with its score: data lineage, model assumptions, and evaluation criteria documented from day one. If a result can't be traced back to its source, we don't ask you to trust it.
Viability analysis and due diligence — corporate, reputational, and asset. Before a single note is written, we hear the organisation as it actually sounds: every record verified, every risk classified and scored.
Strategy and financial models become the written score: three-statement models, scenario analysis, pricing and unit economics built for transparency — instruments a board, a bank, or an investor can read line by line.
Nothing goes on stage untested. Pilots, proofs of concept, and structured validation — we run the piece at small scale, find what falls out of time, and fix it before the audience arrives.
Strategy becomes operation: go-to-market execution, deployed AI systems, automated reporting — measured against the score, corrected in real time. And when the performance ends, we listen again.
Ninety-nine lawsuits read, summarised and scored for probability of loss and financial exposure — R$1.4 billion in gross claims mapped in an interactive risk matrix, with a one-page brief per case. Alongside it, full diligences on prospective buyers, partners and their shareholders, each delivered through our secure client portal.
We rebuilt counterparty diligence as an agent-driven workflow: seven phases across more than thirty public sources, searched by tax ID rather than by name, every piece of evidence timestamped and hashed, homonyms discarded and documented. A senior reviewer signs off a traffic-light decision — the coverage of a three-to-four-week diligence, with under two hours of human time.
Every patient's history is as unique as a fingerprint — and as scattered: lab PDFs, scans, prescriptions and wearable data that never meet. We conceived and built a health tech that joins them into one living record, owned by the patient and trusted by the doctor. AI agents structure every document, each value traced to its source and anything uncertain held for clinical review; an inference layer turns the record into insights for the consultation, never a diagnosis. Now live with real patients, with a patent filing under way.
Developed a comprehensive market entry framework for a mid-cap industrial manufacturer expanding into Latin America — competitive landscape, regulatory mapping, and a phased go-to-market roadmap. The client secured board approval within six weeks.
A selection of representative projects. Client identities are protected under confidentiality agreements.
Whether you're shaping a new venture, preparing for a fundraise, rethinking your business model — or listening to an organisation that isn't quite playing in time — we'd welcome the conversation. Reach out directly, and we'll find a time to connect.
Start the conversation